Have a feature idea you'd love to see implemented?
Let us know!
RMTI Rockwell Medical Inc
Price (delayed)
$2.2
Market cap
$71.1M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.05
Enterprise value
$72.94M
Rockwell Medical is a biopharmaceutical company dedicated to transforming anemia management in a wide variety of therapeutic areas and across the globe, improving the lives of very sick patients. The
Highlights
The gross profit has soared by 105% YoY and by 32% QoQ
RMTI's quick ratio has soared by 94% YoY and by 26% QoQ
Key stats
What are the main financial stats of RMTI
Market
Valuations
Earnings
Shares outstanding
32.32M
Market cap
$71.1M
Enterprise value
$72.94M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.34
Price to sales (P/S)
0.7
EV/EBIT
87.14
EV/EBITDA
14.73
EV/Sales
0.74
Revenue
$98.92M
EBIT
$837,000
EBITDA
$4.95M
Free cash flow
$2.64M
Per share
Balance sheet
Liquidity
EPS
-$0.05
Free cash flow per share
$0.08
Book value per share
$0.94
Revenue per share
$3.14
TBVPS
$1.45
Total assets
$57.08M
Total liabilities
$27.95M
Debt
$14.18M
Equity
$29.14M
Working capital
$20.04M
Debt to equity
0.49
Current ratio
2.41
Quick ratio
1.92
Net debt/EBITDA
0.37
Margins
Efficiency
Dividend
EBITDA margin
5%
Gross margin
16.9%
Net margin
-1.2%
Operating margin
0.6%
Return on assets
-2.3%
Return on equity
-5.2%
Return on invested capital
2.7%
Return on capital employed
2%
Return on sales
0.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RMTI stock price
How has the Rockwell Medical stock price performed over time
Intraday
-5.58%
1 week
-11.65%
1 month
-36.69%
1 year
15.79%
YTD
16.4%
QTD
-44.58%
Financial performance
How have Rockwell Medical's revenue and profit performed over time
Revenue
$98.92M
Gross profit
$16.72M
Operating income
$580,000
Net income
-$1.24M
Gross margin
16.9%
Net margin
-1.2%
Rockwell Medical's operating income has surged by 119% QoQ and by 107% YoY
The company's operating margin has surged by 118% QoQ and by 106% YoY
The gross profit has soared by 105% YoY and by 32% QoQ
The company's net margin has surged by 90% YoY and by 76% QoQ
Growth
What is Rockwell Medical's growth rate over time
Valuation
What is Rockwell Medical stock price valuation
P/E
N/A
P/B
2.34
P/S
0.7
EV/EBIT
87.14
EV/EBITDA
14.73
EV/Sales
0.74
The EPS has soared by 88% YoY and by 71% from the previous quarter
RMTI's price to book (P/B) is 46% lower than its 5-year quarterly average of 4.3 and 16% lower than its last 4 quarters average of 2.8
RMTI's equity is up by 35% year-on-year and by 24% since the previous quarter
RMTI's price to sales (P/S) is 30% lower than its 5-year quarterly average of 1.0
Rockwell Medical's revenue has increased by 22% YoY and by 4.8% from the previous quarter
Efficiency
How efficient is Rockwell Medical business performance
The ROS has soared by 130% from the previous quarter and by 108% YoY
The return on invested capital has surged by 130% since the previous quarter and by 110% year-on-year
RMTI's return on equity has surged by 92% year-on-year and by 76% since the previous quarter
Rockwell Medical's return on assets has surged by 89% YoY and by 75% QoQ
Dividends
What is RMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RMTI.
Financial health
How did Rockwell Medical financials performed over time
Rockwell Medical's total assets is 104% more than its total liabilities
RMTI's quick ratio has soared by 94% YoY and by 26% QoQ
RMTI's current ratio has soared by 83% YoY and by 21% QoQ
The company's debt is 51% lower than its equity
RMTI's equity is up by 35% year-on-year and by 24% since the previous quarter
The debt to equity has contracted by 29% YoY and by 20% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.